[1]
Kwon, D.H. , Kim, G.-Y. , Cha, H.-J. , Kim, S., Kim, H.-S. , Hwang, H.-J. and Choi, Y.H. 2021. Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway. EXCLI Journal. 20, (May 2021), 968-982. DOI:https://doi.org/10.17179/excli2021-3506.